MA32407B1 - Sels et polymorphes d'un composé tétracycline - Google Patents

Sels et polymorphes d'un composé tétracycline

Info

Publication number
MA32407B1
MA32407B1 MA33447A MA33447A MA32407B1 MA 32407 B1 MA32407 B1 MA 32407B1 MA 33447 A MA33447 A MA 33447A MA 33447 A MA33447 A MA 33447A MA 32407 B1 MA32407 B1 MA 32407B1
Authority
MA
Morocco
Prior art keywords
tetracycline compound
tetracycline
treatment
compound
polymorphic salts
Prior art date
Application number
MA33447A
Other languages
Arabic (ar)
English (en)
Inventor
Raymond Cvetovich
Tadeusz Warchol
Original Assignee
Paratek Pharm Innc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paratek Pharm Innc filed Critical Paratek Pharm Innc
Publication of MA32407B1 publication Critical patent/MA32407B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)

Abstract

L'invention concerne des formes cristallines, y compris des sels et polymorphes, d'un composé utile dans le traitement d'états réactifs à un composé tétracycline. Les composés cristallins sont utiles pour le traitement et la prévention d'affections et troubles tels que des infections bactériennes et des néoplasmes, ainsi que d'autres applications connues pour les composés tétracycline en général.
MA33447A 2008-05-23 2010-12-20 Sels et polymorphes d'un composé tétracycline MA32407B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12871208P 2008-05-23 2008-05-23
PCT/US2009/045143 WO2009143509A1 (fr) 2008-05-23 2009-05-26 Sels et polymorphes d’un composé tétracycline

Publications (1)

Publication Number Publication Date
MA32407B1 true MA32407B1 (fr) 2011-06-01

Family

ID=41340587

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33447A MA32407B1 (fr) 2008-05-23 2010-12-20 Sels et polymorphes d'un composé tétracycline

Country Status (30)

Country Link
US (4) US8383610B2 (fr)
EP (3) EP2296464B1 (fr)
JP (6) JP5727930B2 (fr)
KR (1) KR101679362B1 (fr)
CN (4) CN108324722A (fr)
AR (1) AR075447A1 (fr)
AU (2) AU2009248795B2 (fr)
BR (1) BRPI0913026B1 (fr)
CA (2) CA2724897C (fr)
CO (1) CO6300898A2 (fr)
CY (2) CY1116436T1 (fr)
DK (2) DK2807926T3 (fr)
EC (1) ECSP10010704A (fr)
ES (2) ES2842204T3 (fr)
HK (2) HK1154757A1 (fr)
HR (2) HRP20150584T1 (fr)
HU (1) HUE053038T2 (fr)
IL (1) IL209414A0 (fr)
LT (1) LT2807926T (fr)
MA (1) MA32407B1 (fr)
MX (1) MX2010012622A (fr)
MY (1) MY156254A (fr)
NZ (2) NZ598154A (fr)
PL (2) PL2296464T3 (fr)
PT (2) PT2296464E (fr)
RU (1) RU2500665C2 (fr)
SI (2) SI2807926T1 (fr)
TW (5) TW202332671A (fr)
WO (1) WO2009143509A1 (fr)
ZA (1) ZA201008390B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008246119A1 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
WO2009111064A2 (fr) 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Composés de minocycline et procédés d’utilisation de ceux-ci
TW202332671A (zh) * 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
EP3574908B8 (fr) 2011-05-12 2024-09-11 Almirall LLC Composition pharmaceutique pour adminstration par voie orale comprenant des sels cristallins d'amide de l'acide (4s,4as,5ar,12as)-4-diméthylamino- 3,10,12,12a-tétrahydroxy-7-[(méthoxy(méthyl)amino)-méthyl]- 1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphtacène-2-carboxylique
PT108223B (pt) * 2015-02-13 2018-05-08 Hovione Farm S A Novas formas polimórficas de minociclina base e processos para a sua preparação
JP6793715B2 (ja) 2015-03-23 2020-12-02 バイオファーミクス・インコーポレイテッドＢｉｏＰｈａｒｍＸ， Ｉｎｃ． テトラサイクリンの皮膚用医薬組成物
SG10201913559VA (en) * 2016-03-24 2020-02-27 Paratek Pharm Innc Methods for treating and preventing c. difficile infection
WO2017192516A1 (fr) * 2016-05-02 2017-11-09 Paratek Pharmaceuticals, Inc. Composés de 9-aminométhyl-minocycline et leurs procédés d'utilisation dans le traitement de l'infection des voies urinaires (ivu)
MX2019000086A (es) * 2016-06-22 2019-05-02 Kbp Biosciences Co Ltd Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un metodo para la preparacion de las mismas.
TW202206081A (zh) * 2016-08-03 2022-02-16 美商派瑞泰Ｓｐｖ２有限公司 ９—胺甲基米諾四環素化合物及其用途
CN113559102B (zh) * 2016-10-03 2023-01-03 布利本迅药业(上海)有限公司 包括trh类似物和丙基辛酸的组合的组合物和丙基辛酸的药学上可接受的盐
EP3534908A4 (fr) 2016-11-01 2020-05-27 Paratek Pharmaceuticals, Inc. Composés de 9-aminométhylminocycline et leur utilisation dans le traitement de la pneumonie bactérienne d'acquisition communautaire (cabp)
RU2632708C1 (ru) * 2016-11-14 2017-10-09 Лонг Шенг Фарма Лимитед Способ получения комбинированного антибактериального препарата
CN111484424B (zh) * 2020-04-14 2022-10-25 成都百特万合医药科技有限公司 一种合成奥马环素的方法
EP4165016A4 (fr) * 2020-06-11 2024-07-10 Paratek Pharm Innc Formes cristallines d'omadacycline, leurs procédés de synthèse et leurs procédés de préparation
PT117254B (pt) 2021-05-26 2024-04-18 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas
CN113433249B (zh) * 2021-07-21 2023-03-24 河北圣雪大成制药有限责任公司 一种高效液相色谱法检测米诺环素中间体有关物质的方法
CN113929593B (zh) * 2021-09-02 2024-05-31 河北圣雪大成唐山制药有限责任公司 一种土霉素-2,5-二羟基苯甲酸共晶及其制备方法
WO2023047323A1 (fr) * 2021-09-24 2023-03-30 Glenmark Life Sciences Limited Procédé de préparation de tosylate d'omadacycline

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US2980584A (en) * 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US3062717A (en) * 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3019260A (en) * 1959-05-13 1962-01-30 American Cyanamid Co Process for the catalytic reduction of 6-hydroxy hydronaphthacenes
FR1430859A (fr) * 1960-05-23 1966-05-25
US3165531A (en) 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
DK122658B (da) * 1963-06-17 1972-03-27 Novo Terapeutisk Labor As Fremgangsmåde til udfældning af tetracyclinbase i krystallinsk form.
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
US3304227A (en) * 1965-07-15 1967-02-14 Loyal E Loveless Antibiotic-containing animal feed
NL6607516A (fr) * 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
NL158172B (nl) * 1972-09-18 1978-10-16 Farmaceutici Italia Werkwijze voor het bereiden van tetracyclinederivaten met een substituent op de 7-plaats.
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
USRE34656E (en) * 1983-12-29 1994-07-05 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency
US4925833A (en) 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US4935412A (en) * 1983-12-29 1990-06-19 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4666897A (en) 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4704383A (en) 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
JP3016587B2 (ja) 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
US5308839A (en) 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
DE4042402C1 (fr) 1990-10-03 1992-09-03 Degussa Ag, 6000 Frankfurt, De
US5770588A (en) 1991-02-11 1998-06-23 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
US5231017A (en) 1991-05-17 1993-07-27 Solvay Enzymes, Inc. Process for producing ethanol
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
DE122006000058I1 (de) 1991-10-04 2007-01-18 Wyeth Corp 7-Substituierte-9-substituierte Amino-6-Demethyl-6-Deoxy-Tetracycline
US5258371A (en) 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
US6043225A (en) 1992-06-12 2000-03-28 Board Of Regents Of The University Of Washington Diagnosis and treatment of arterial chlamydial granuloma
EP0599397B1 (fr) 1992-11-17 1996-08-28 The Research Foundation Of State University Of New York Tétracyclines comprenant les tétracyclines modifiées chimiquement afin d'être non-antimicrobiennes inhibent la réticulation excessive du collagène lors du diabète
US6043231A (en) 1993-03-02 2000-03-28 The Research Foundation Of State Univ. Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5523297A (en) 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5668122A (en) * 1993-07-28 1997-09-16 Fife; Rose S. Method to treat cancer with tetracyclines
US5834450A (en) * 1994-02-17 1998-11-10 Pfizer Inc. 9- (substituted amino) -alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US5843925A (en) 1994-12-13 1998-12-01 American Cyanamid Company Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
US5834449A (en) 1996-06-13 1998-11-10 The Research Foundation Of State University Of New York Treatment of aortic and vascular aneurysms with tetracycline compounds
US5827840A (en) 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5919774A (en) 1996-12-10 1999-07-06 Eli Lilly And Company Pyrroles as sPLA2 inhibitors
US5837696A (en) 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth
US5773430A (en) 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline
US6277067B1 (en) 1997-04-04 2001-08-21 Kerry L. Blair Method and portable colposcope useful in cervical cancer detection
US5929055A (en) * 1997-06-23 1999-07-27 The Research Foundation Of State University Of New York Therapeutic method for management of diabetes mellitus
US6277061B1 (en) 1998-03-31 2001-08-21 The Research Foundation Of State University Of New York Method of inhibiting membrane-type matrix metalloproteinase
US6015804A (en) 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5977091A (en) 1998-09-21 1999-11-02 The Research Foundation Of State University Of New York Method of preventing acute lung injury
US5998390A (en) 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
WO2000028983A1 (fr) 1998-11-18 2000-05-25 Collagenex Pharmaceuticals, Inc. Nouveaux derives de 4-dedimethy laminotetra cycline
DE19938198A1 (de) * 1999-08-12 2001-03-01 Deutsche Telekom Ag Verfahren zum Etablieren eines gemeinsamen Schlüssels für eine Gruppe von mindestens drei Teilnehmern
US6231894B1 (en) 1999-10-21 2001-05-15 Duke University Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
US7231517B1 (en) * 2000-03-03 2007-06-12 Novell, Inc. Apparatus and method for automatically authenticating a network client
CN100473644C (zh) * 2000-07-07 2009-04-01 塔夫茨大学信托人 9-取代的二甲胺四环素化合物
CN102336679A (zh) * 2000-07-07 2012-02-01 塔夫茨大学信托人 7-取代的四环素化合物
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
JP2005506291A (ja) 2001-03-13 2005-03-03 パラテック ファーマシューティカルズ， インク． ７，９−置換テトラサイクリン化合物
WO2003004009A1 (fr) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Formulation a compression directe de medicaments faiblement compressibles tels que le chlorhydrate de metformine
EP2311451A1 (fr) * 2002-03-08 2011-04-20 Paratek Pharmaceuticals, Inc. Composés de tétracycline à substitution amino-méthyle
JP4099039B2 (ja) * 2002-11-15 2008-06-11 松下電器産業株式会社 プログラム更新方法
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
JP4712325B2 (ja) * 2003-09-12 2011-06-29 株式会社リコー 通信装置、通信システム、通信方法及びプログラム
US8015399B2 (en) * 2003-09-30 2011-09-06 Ricoh Company, Ltd. Communication apparatus, communication system, certificate transmission method and program
JP4621200B2 (ja) * 2004-04-15 2011-01-26 パナソニック株式会社 通信装置、通信システム及び認証方法
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
EP1991236A2 (fr) * 2006-01-24 2008-11-19 Paratek Pharmaceuticals, Inc. Procede permettant d'accroitre la biodisponibilite orale de tetracyclines
EP2857386B1 (fr) * 2006-04-24 2017-02-22 Teva Pharmaceutical Industries Ltd Formes cristallines de tigécycline et leurs procédés de préparation
CN101134733A (zh) * 2007-09-24 2008-03-05 合肥信风科技开发有限公司 一种替加环素的物质形态及其制备方法
WO2009111064A2 (fr) * 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Composés de minocycline et procédés d’utilisation de ceux-ci
PT2271348T (pt) * 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
TW202332671A (zh) * 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體

Also Published As

Publication number Publication date
EP2807926B1 (fr) 2020-10-07
CA2724897C (fr) 2017-12-19
AU2009248795A1 (en) 2009-11-26
US8383610B2 (en) 2013-02-26
CN102105058B (zh) 2015-11-25
KR101679362B1 (ko) 2016-11-25
EP2807926A1 (fr) 2014-12-03
EP2296464A1 (fr) 2011-03-23
CN105348138A (zh) 2016-02-24
AU2009248795B2 (en) 2016-08-25
ES2842204T3 (es) 2021-07-13
TWI585071B (zh) 2017-06-01
CY1123705T1 (el) 2022-03-24
SI2807926T1 (sl) 2021-03-31
CN104844472A (zh) 2015-08-19
CY1116436T1 (el) 2017-02-08
TW202021946A (zh) 2020-06-16
JP2015166350A (ja) 2015-09-24
KR20110022619A (ko) 2011-03-07
TW201741281A (zh) 2017-12-01
LT2807926T (lt) 2021-02-10
DK2296464T3 (en) 2015-06-15
DK2807926T3 (da) 2021-01-11
CN108324722A (zh) 2018-07-27
PT2296464E (pt) 2015-07-13
BRPI0913026A2 (pt) 2019-08-27
EP2296464A4 (fr) 2011-05-18
RU2500665C2 (ru) 2013-12-10
US20140005420A1 (en) 2014-01-02
SI2296464T1 (sl) 2015-07-31
US20160324879A1 (en) 2016-11-10
JP5727930B2 (ja) 2015-06-03
CA2724897A1 (fr) 2009-11-26
JP2017149750A (ja) 2017-08-31
PL2807926T3 (pl) 2021-05-31
NZ598154A (en) 2013-05-31
HK1204526A1 (en) 2015-11-27
WO2009143509A1 (fr) 2009-11-26
US9227921B2 (en) 2016-01-05
CA2987354A1 (fr) 2009-11-26
JP2011520988A (ja) 2011-07-21
EP3827817A1 (fr) 2021-06-02
JP6129235B2 (ja) 2017-05-17
CO6300898A2 (es) 2011-07-21
ZA201008390B (en) 2014-03-26
AR075447A1 (es) 2011-04-06
MX2010012622A (es) 2010-12-21
HK1154757A1 (en) 2012-05-04
AU2016262682B2 (en) 2018-06-28
HRP20202081T1 (hr) 2021-02-19
US20100113399A1 (en) 2010-05-06
CN104844472B (zh) 2018-02-13
JP2022189916A (ja) 2022-12-22
JP2021011498A (ja) 2021-02-04
NZ589574A (en) 2012-04-27
TWI680117B (zh) 2019-12-21
HRP20150584T1 (hr) 2015-07-03
IL209414A0 (en) 2011-01-31
TW202216656A (zh) 2022-05-01
PT2807926T (pt) 2021-01-12
TW202332671A (zh) 2023-08-16
TW201000433A (en) 2010-01-01
US20180104262A1 (en) 2018-04-19
ECSP10010704A (es) 2011-01-31
RU2010152758A (ru) 2012-06-27
BRPI0913026B1 (pt) 2022-03-03
JP2019052184A (ja) 2019-04-04
PL2296464T3 (pl) 2015-08-31
ES2538364T3 (es) 2015-06-19
AU2016262682A1 (en) 2016-12-15
CN102105058A (zh) 2011-06-22
MY156254A (en) 2016-01-29
EP2296464B1 (fr) 2015-03-04
HUE053038T2 (hu) 2021-06-28

Similar Documents

Publication Publication Date Title
MA32407B1 (fr) Sels et polymorphes d'un composé tétracycline
MA31373B1 (fr) Composes amino-heterocycliques
MA32104B1 (fr) Dérivés d'oxime en tant qu'inhibiteurs de hsp90
MA39777B1 (fr) Composes organiques de la famille des monobactams pour le traitement d'infections bactériennes
UY31084A1 (es) Compuestos de azaindol para la inhibicion de b-secretasa
MA31741B1 (fr) Derives fongicides de 2-alkylthio-2-quinolinyloxy- acetamide
ATE482947T1 (de) Neues salz und polymorph des dpp-iv-hemmers
UY31083A1 (es) Derivados de sulfoximinas para la inhibicion de b-secretasa
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
MA37383A1 (fr) Compose heterobicycliques comme inhibiteurs de la beta lactamase
MA33407B1 (fr) Composes bicycliques et tricycliques servant d'inhibiteurs de kat ii
MA33636B1 (fr) Dérivés aminopropioniques substitués comme inhibiteurs de néprilysine
MA30532B1 (fr) Sulfonamides tricycliques condenses inhibiteurs de gamma-secretase
TW200738688A (en) Compounds for the treatment of inflammatory disorders
MA34234B1 (fr) Composes pyrazol-4-yl-heterocyclyle-carboxamide et leurs procedes d'utilisation
MA32904B1 (fr) Composes de purine
MA30781B1 (fr) Inhibiteur de kinase
MX2009012163A (es) Hetarilanilinas como moduladores para beta-amiloide.
ECSP055910A (es) Nuevos acidos carboxilicos y sus esteres, medicamentos que contienen estos compuestos y procedimientos para su preparacion
MA37886A1 (fr) Nouvelles pyridinones bicycliques
MA33358B1 (fr) Arylpyridine en tant qu'inhibiteurs de l'aldostérone synthase
MA35285B1 (fr) Indazoles
MA31400B1 (fr) Composes organiques
MA32558B1 (fr) Composes organiques
MA31979B1 (fr) (cyclopropylphenyl) phenyloxamides, leur procede de production et leur utilisation comme medicament